Max Robotics — Global Service Robot Directory + US Certification

About

Paul Mansfield is a pioneering surgical oncologist whose work centers on the advancement of robotic gastrectomy for gastric and gastroesophageal junction cancers. His research has been instrumental in defining the safety, oncological quality, and economic viability of robotic approaches in foregut surgery. Through landmark studies using the National Cancer Database, Mansfield has demonstrated nationwide improvements in short-term outcomes and oncological metrics during the implementation of robotic gastrectomy programs, with his most-cited work accumulating over 16 citations. He has also contributed critical insights into opioid use reduction in robotic versus open procedures and pioneered fluorescent-image guidance for precise subtotal gastrectomy. Notable achievements include developing evidence-based techniques for robotic transhiatal lower mediastinal dissection and esophagojejunostomy, as well as conducting the first comprehensive cost analysis comparing robotic and open gastrectomy. His work at a major cancer center has established shared procedural steps for robotic pancreatoduodenectomy and gastrectomy, shaping best practices in minimally invasive foregut surgery. With a growing body of work that bridges technical innovation, patient safety, and healthcare economics, Mansfield is a leading voice in the evolution of robotic surgical oncology.